[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]
Browsing Category
Life Sciences
Genomic Vision Joins France BioLead to Advance Innovation and Production of Biopharmaceuticals in…
Participation in France BioLead reflects the Company's growing focus on innovation for bioproduction in line with its strategy to accelerate…
Lunaphore Expands Its COMET Portfolio to Become the First Universal, End-to-end Spatial Biology…
Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, announced the launch of a full expansion…
TeselaGen Offers its Starter Edition to Help BioTech Startups Scale Efficiently
TeselaGen Biotechnology Inc., the company developing the AI-enabled Operating System for Biotechnology R&D and Manufacturing, announces the launch…
Dante Genomics Launches Avanti Software for a Plug-And-Play Genomic Interpretation That Takes…
Dante Genomics, a global leader in genomics and precision medicine, launched the beta version of Avanti, the Company's proprietary B2B software for…
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable…
Culture Biosciences Focuses Technology and Service Platform on Biologics
Intelligent upstream bioprocess development for therapeutics using an integrated platform of cloud-based software, single-use bioreactors, simulation…
Celmatix and Global Collaborators Announce Findings from Largest Genetic Study to Date on…
Results reveal genetic basis of disease and link to other chronic pain conditions such as migraine and back pain that have implications for novel…
QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of…
QSAM Biosciences, a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment…
GIO World Health Ltd, a Leading Stem Cell Life Science Company, Announces Plans to Go Public
GIO World Health Ltd (“GIO World Health”) has entered into a business combination agreement with Apeiron Capital Investment Corp (APNC).…
Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhibitor and Secures $60 Million in Series…
Volastra Therapeutics, a clinical stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), announced completion of the…